SEGMENT AND GEOGRAPHIC INFORMATION (Tables)

12 Months Ended

Dec. 31, 2018

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

Net sales and profit by reportable segment for the years ended December 31, 2018, 2017 and 2016 are as follows:

	Years Ended December 31,
	2018			2017			2016
	(In thousands)
Segment Net Sales
Codman Specialty Surgical	$	963,929		$	720,301		$	632,524
Orthopedics and Tissue Technologies	508,512			467,935			359,551
Total revenues	$	1,472,441		$	1,188,236		$	992,075
Segment Profit
Codman Specialty Surgical	$	363,336		$	292,971		$	256,629
Orthopedics and Tissue Technologies	149,510			129,697			103,852
Segment profit	512,846			422,668			360,481
Amortization	(21,160)			(20,370)			(13,862)
Corporate and other	(380,688		)	(357,494		)	(231,279		)
Operating income	$	110,998		$	44,804		$	115,340

The Company does not allocate any assets to the reportable segments. No asset information is reported to the chief operating decision maker and disclosed in the financial information for each segment.

The Company attributes revenue to geographic areas based on the location of the customer. Total revenue, net and long-lived assets (tangible) by major geographic area are summarized below:

	United States*		Europe		Asia Pacific		Rest of the World		Consolidated
	(In thousands)
Total revenue, net:
2018	$	1,045,887	$	201,354	$	144,253	$	80,947	$	1,472,441
2017	894,260		150,147		80,636		63,193		1,188,236
2016	765,608		120,588		59,985		45,894		992,075
Total long-lived assets:
2018	$	280,382	$	32,679	$	3,765	$	3,203	$	320,029
2017	247,154		30,942		4,189		3,044		285,329

* Includes long-lived assets in Puerto Rico.